Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus
Background: Type 2 Diabetes Mellitus (T2DM) represents one of the most important risk factors for atrial fibrillation (AF). Numerous studies have shown that T2DM and poor glycemic control reflected by glycated hemoglobin A1c (HbA1c) levels are independently associated with new onset AF. Recent ex...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Masters Program in Public Health, Universitas Sebelas Maret
2016-01-01
|
Series: | Indonesian Journal of Medicine |
Subjects: | |
Online Access: | http://theijmed.com/index.php?journal=theijmed&page=article&op=view&path%5B%5D=12&path%5B%5D=19 |
id |
doaj-279072ef6c34467aaa3644d54b7291ea |
---|---|
record_format |
Article |
spelling |
doaj-279072ef6c34467aaa3644d54b7291ea2020-11-25T01:30:42ZengMasters Program in Public Health, Universitas Sebelas MaretIndonesian Journal of Medicine2549-02652016-01-0111587010.26911/theijmed.2016.01.01.08Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus Isyana Miranti K0Trisulo Wasyanto1Bhisma Murti2Biomedic, Family Medicine Program, Sebelas Maret University, SurakartaBiomedic, Family Medicine Program, Sebelas Maret University, SurakartaMasters Program in Public Health, Sebelas Maret University, SurakartaBackground: Type 2 Diabetes Mellitus (T2DM) represents one of the most important risk factors for atrial fibrillation (AF). Numerous studies have shown that T2DM and poor glycemic control reflected by glycated hemoglobin A1c (HbA1c) levels are independently associated with new onset AF. Recent experimental studies reported that the increased susceptibility to AF in the diabetic patients was presumably due to the slowing of conduction associated with increased interstitial fibrosis. Systemic inflammation cam play role in the development of atrial fibrillation. Highsensitivity C-reactive protein (hsCRP) is an inflammatory biomarker that independently predicts the cardiovascular risk. This study aimed to determine the association between hsCRP level and glycemic control with total interatrial conduction time in T2DM patients. Subjects and Method: This was an observational analytic study with cross-sectional design. A total of samples were 41 patients with T2DM. Peripheral venous blood samples to measure hsCRP and HbA1c were drawn in all study population. The total interatrial conduction time was measured by tissue Doppler echocardiography.Multivariate analysis was performed using multiple regression analysis. p< 0.050 was considered to indicate a statistically significant difference. Results: The high-sensitivity C-reactive protein level was higher in the T2DM patients with HbA1c≥7% than in the T2DM patients with HbA1c<7%, but not statistically significant (0.44±0.30 vs 0.32±0.22; p= 0.183). The total atrial conduction time was longer in the T2DM patients with HbA1c≥7% than in T2DM patients with HbA1c<7%, but not statistically significant (100.29±28.53 vs 94.88±16.50; p= 0.449). Multiple regression analysis showed that hsCRP levels and glycemic control had significant positive correlation with total interatrial conduction time in T2DM patients (r= 0.51; p= 0.004). Conclusion: The hsCRP levels and glycemic control were significant positively correlated with total interatrium conduction time in patients with type 2 diabetes. Keywords: hsCRP, glycemic control, HbA1c, total interatrial conduction time Correspondence: Isyana Miranti K. Biomedic, Family Medicine Program, Sebelas Maret University, Surakarta. http://theijmed.com/index.php?journal=theijmed&page=article&op=view&path%5B%5D=12&path%5B%5D=19hsCRPglycemic controlHbA1ctotal interatrial conduction time |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Isyana Miranti K Trisulo Wasyanto Bhisma Murti |
spellingShingle |
Isyana Miranti K Trisulo Wasyanto Bhisma Murti Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus Indonesian Journal of Medicine hsCRP glycemic control HbA1c total interatrial conduction time |
author_facet |
Isyana Miranti K Trisulo Wasyanto Bhisma Murti |
author_sort |
Isyana Miranti K |
title |
Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus |
title_short |
Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus |
title_full |
Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus |
title_fullStr |
Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus |
title_full_unstemmed |
Association between hsCRP Levels, Glycemic Control and Total Interatrial Conduction Time in Patients with Type 2 Diabetes Mellitus |
title_sort |
association between hscrp levels, glycemic control and total interatrial conduction time in patients with type 2 diabetes mellitus |
publisher |
Masters Program in Public Health, Universitas Sebelas Maret |
series |
Indonesian Journal of Medicine |
issn |
2549-0265 |
publishDate |
2016-01-01 |
description |
Background: Type 2 Diabetes Mellitus (T2DM) represents one of the most important risk factors
for atrial fibrillation (AF). Numerous studies have shown that T2DM and poor glycemic control
reflected by glycated hemoglobin A1c (HbA1c) levels are independently associated with new onset
AF. Recent experimental studies reported that the increased susceptibility to AF in the diabetic
patients was presumably due to the slowing of conduction associated with increased interstitial
fibrosis. Systemic inflammation cam play role in the development of atrial fibrillation. Highsensitivity
C-reactive protein (hsCRP) is an inflammatory biomarker that independently predicts
the cardiovascular risk. This study aimed to determine the association between hsCRP level and
glycemic control with total interatrial conduction time in T2DM patients.
Subjects and Method: This was an observational analytic study with cross-sectional design. A
total of samples were 41 patients with T2DM. Peripheral venous blood samples to measure hsCRP
and HbA1c were drawn in all study population. The total interatrial conduction time was measured
by tissue Doppler echocardiography.Multivariate analysis was performed using multiple regression
analysis. p< 0.050 was considered to indicate a statistically significant difference.
Results: The high-sensitivity C-reactive protein level was higher in the T2DM patients with
HbA1c≥7% than in the T2DM patients with HbA1c<7%, but not statistically significant (0.44±0.30
vs 0.32±0.22; p= 0.183). The total atrial conduction time was longer in the T2DM patients with
HbA1c≥7% than in T2DM patients with HbA1c<7%, but not statistically significant (100.29±28.53
vs 94.88±16.50; p= 0.449). Multiple regression analysis showed that hsCRP levels and glycemic
control had significant positive correlation with total interatrial conduction time in T2DM patients
(r= 0.51; p= 0.004).
Conclusion: The hsCRP levels and glycemic control were significant positively correlated with
total interatrium conduction time in patients with type 2 diabetes.
Keywords: hsCRP, glycemic control, HbA1c, total interatrial conduction time
Correspondence:
Isyana Miranti K. Biomedic, Family Medicine Program, Sebelas Maret University, Surakarta. |
topic |
hsCRP glycemic control HbA1c total interatrial conduction time |
url |
http://theijmed.com/index.php?journal=theijmed&page=article&op=view&path%5B%5D=12&path%5B%5D=19 |
work_keys_str_mv |
AT isyanamirantik associationbetweenhscrplevelsglycemiccontrolandtotalinteratrialconductiontimeinpatientswithtype2diabetesmellitus AT trisulowasyanto associationbetweenhscrplevelsglycemiccontrolandtotalinteratrialconductiontimeinpatientswithtype2diabetesmellitus AT bhismamurti associationbetweenhscrplevelsglycemiccontrolandtotalinteratrialconductiontimeinpatientswithtype2diabetesmellitus |
_version_ |
1725090557578969088 |